openPR Logo
Press release

Global Oncology Radiation Therapy Market Technology 2023

12-23-2016 08:02 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Global Oncology Radiation Therapy Market Technology 2023

Radiation therapy refers to the medical use of targeted energy such as radioactive substances, x-rays etc., to destroy or kill cancerous cells without affecting the nearby healthy tissues. This therapy can be deployed as a sole therapy or as an adjuvant therapy, or it can also be employed to shrink the tumor cells, reduce pain and pressure or any other symptoms of cancer (also known as palliative radiation therapy). Currently, acceptance of radiation therapy is increasing owing to the consistent rise in cancer incidence worldwide. As per the updates published by World Health Organization (WHO), in February 2015, cancer is among the leading causes of mortality and morbidity across the globe with approximately 14 million new cases and around 8.2 million cancer related deaths in 2012.

In majority of cancer treatments, radiation therapy acts as an effective treatment option; however, other types of cancers may respond to combination treatment options such as surgery, chemotherapy or immunotherapy. External and internal radiation therapies constitute the two major cancer treatment options. Systemic radiation therapy, intraoperative radiation therapy, radioimmunotherapy and radiosensitizers and radioprotectors represent other types of oncology radiation therapies. External beam radiation therapy involves the transmission of radiation through a machine positioned outside the body and encompasses several types such as stereotactic radiation therapy, proton beam therapy, 3-D conformal radiation therapy and intensity modulated radiation therapy.

Request a PDF Brochure with Report Analysis:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4333

On the other hand, internal radiation therapy also referred to as brachytherapy involves the placement of a radioactive material (implant) via catheter or a carrier at the tumor site and the tissue surrounding it. These radioactive implants may either be temporary or permanent and may demand hospital stay. With time, these implants lose their radioactivity but inactive seeds remain in the body. Other treatment options such as systemic radiation therapy involve the use of radioactive materials such as strontium-89 or iodine-131 which travel in the blood to kill cancerous cells while radioimmunotherapy involves the use of monoclonal antibodies that deliver radiation directly to the cancer cells.

The market for oncology radiation therapy can be majorly segmented on the basis of type of method, radiation source and application. Based on the type of method, radiation therapy can be further categorized into stereotactic radiotherapy and stereotactic radiosurgery. Type of radiation source can be further classified into two major sub segments namely external beam radiation therapy and internal radiation therapy along with their technologies. Use of radiation therapy in treatment of various cancers such as colorectal, breast, lung and prostate represents the application areas of oncology radiation therapy market. Geographically, North American and European countries represent the major revenue contributors owing to consistent technological advances followed by rigorous research initiatives to identify novel treatment methods. Asia Pacific and LATAM regions provide lucrative opportunities for the growth and acceptance of radiation therapies in cancer treatment. Safety regulations and reimbursement policies for radiation therapies govern the market growth.

The major factors favoring market growth are increasing cancer incidence followed by consistent technological advances in cancer research and treatment measures. In addition, consistent rise in geriatric population along with favorable reimbursement policies will propel the market growth. On the other hand, harmful side effects of radiation therapy followed by high cost of the procedures are the major factors that might hamper the market growth. Furthermore, factors such as lack of adequate infrastructure in conjunction with increasing healthcare expenditure might further limit the market growth. Accuray, Inc., Boston Scientific Corporation, Brainlab AG, C.R. Bard, Inc., GE Healthcare, NTP Radioisotopes (pty) Ltd., Positron Corporation, Siemens Healthcare and Varian Medical Systems, Inc. are some of the players operating in this market.

Browse Full Research Report on Oncology Radiation Therapy Market:
http://www.transparencymarketresearch.com/oncology-radiation-therapy-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Oncology Radiation Therapy Market Technology 2023 here

News-ID: 400494 • Views: 402

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Radiation

Global Radiation-Hardened Electronics Market Report
According to a new market research report published by Global Market Estimates, the Radiation-Hardened Electronics Market is denoted to portray a sumptuous improvement of 3.5% during the forecast period (2020-2026). The devices or systems used to shield the effect of ionizing radiation on various electronic and semiconductor elements are called radiation-hardened electronics. The application of radiation-hardened electronics is used in verticals like space, Defense, and automotive. The scope of the
Radiation Dose Management Market: Safety Concerns against Adverse Effects of Rad …
Transparency Market Research has published a new report titled, “Radiation Dose Management Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026”. According to the report, the global radiation dose management market was valued at US$ 143.2 Mn in 2017 and is projected to expand at a CAGR of 26.7% from 2018 to 2026 to reach US$ 1,361.5 Mn in 2026. Read Report Overview - https://www.transparencymarketresearch.com/radiation-dose-management-market.html Rise in prevalence
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market …
QY Market Insights added Latest Research Report titled Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market 2018 by Manufacturers, Regions, Product Type and Application, Forecast to 2025 to its Large Report database. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing capital structure of the Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market. Get Free Sample Report at: https://www.qymarketinsights.com/report-detail/54739/request-sample The Report highlights key
Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market …
Qyresearchreports include new market research report "Global Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) Market Size, Status and Forecast 2025" to its huge collection of research reports. A newly added research report about the global market for Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) produces a 360-degree overview of it. The report brings to the fore important details and elucidates every aspect expected to mold its path going forward. It sheds
Global Radiation Toxicity Market: Radiation Sickness, Acute Radiation Syndrome - …
"The Latest Research Report Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)-Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Radiation ToxicityRadiation Toxicity Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome)-Pipeline Review, H2 2017, provides an overview of the Radiation Toxicity (Radiation Sickness, Acute Radiation Syndrome) (Toxicology) pipeline landscape. Radiation Toxicity
Global Radiation Therapy Market Report: 2016 Edition
Radiation depicts the way energy moves from one place to another. One of the top advancements in the field of radiotherapy has been the development of proton treatment as well development of linear accelerators. Proton treatment, likewise called proton beam treatment, is a kind of radiation treatment that uses protons instead of x-beams to treat disease. It is a very precise strategy for radiotherapy which is suitable for all patients